Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study.

Dischereit G, Tarner IH, Müller-Ladner U, Lange U.

Clin Rheumatol. 2013 Mar;32(3):377-81. doi: 10.1007/s10067-012-2128-8. Epub 2012 Nov 24. No abstract available.

PMID:
23179009
2.

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.

Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.

Ann Rheum Dis. 2008 Mar;67(3):353-7. Epub 2007 Jul 20.

PMID:
17644538
3.

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.

Ann Rheum Dis. 2009 Mar;68(3):373-6. doi: 10.1136/ard.2008.091611. Epub 2008 Apr 13.

4.

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.

Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF.

Ann Rheum Dis. 2006 Nov;65(11):1495-9. Epub 2006 Apr 10.

5.

The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.

Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH.

Joint Bone Spine. 2011 Mar;78(2):188-93. doi: 10.1016/j.jbspin.2010.05.010.

PMID:
20621536
6.

Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.

Barnabe C, Hanley DA.

Semin Arthritis Rheum. 2009 Oct;39(2):116-22. doi: 10.1016/j.semarthrit.2008.04.004. Epub 2008 Jun 30. Review.

PMID:
18585759
7.

Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.

Marzo-Ortega H, McGonagle D, Jarrett S, Haugeberg G, Hensor E, O'connor P, Tan AL, Conaghan PG, Greenstein A, Emery P.

Ann Rheum Dis. 2005 Nov;64(11):1568-75. Epub 2005 Apr 13.

8.

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis.

Visvanathan S, van der Heijde D, Deodhar A, Wagner C, Baker DG, Han J, Braun J.

Ann Rheum Dis. 2009 Feb;68(2):175-82. doi: 10.1136/ard.2007.084426. Epub 2008 May 21.

9.

Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis.

Toktas H, Okur E, Dundar U, Dikici A, Kahveci OK.

Clin Rheumatol. 2014;33(10):1481-7. doi: 10.1007/s10067-014-2625-z. Epub 2014 Apr 27.

PMID:
24770796
10.

Bone mineral density in patients with rheumatoid arthritis treated with infliximab.

Vis M, Voskuyl AE, Wolbink GJ, Dijkmans BA, Lems WF; OSTRA Study Group.

Ann Rheum Dis. 2005 Feb;64(2):336-7. No abstract available.

11.

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.

Lange U, Teichmann J, Müller-Ladner U, Strunk J.

Rheumatology (Oxford). 2005 Dec;44(12):1546-8. Epub 2005 Nov 1.

12.

[Are there any positive effects of TNF-alpha blockers on bone metabolism?].

Seriolo B, Paolino S, Sulli A, Cutolo M.

Reumatismo. 2006 Jul-Sep;58(3):199-205. Italian.

13.
14.
15.

Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.

Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA.

J Rheumatol. 2006 May;33(5):921-3. Epub 2006 Mar 15.

PMID:
16541480
16.

The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis.

Kang KY, Ju JH, Park SH, Kim HY.

Rheumatology (Oxford). 2013 Apr;52(4):718-26. doi: 10.1093/rheumatology/kes364. Epub 2012 Dec 28.

17.

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.

Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA.

Ann Rheum Dis. 2005 May;64(5):765-6. Epub 2004 Sep 30.

18.
19.

Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis.

Haroon NN, Sriganthan J, Al Ghanim N, Inman RD, Cheung AM.

Semin Arthritis Rheum. 2014 Oct;44(2):155-61. doi: 10.1016/j.semarthrit.2014.05.008. Epub 2014 May 9. Review.

PMID:
24909809
20.
Items per page

Supplemental Content

Write to the Help Desk